Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of the integrity of real-time electronic health record data used in clinical research.

PloS one·2026
Same author

Clinical Trial Patient Matching: A Real-Time, Common Data Model and Artificial Intelligence-Driven System for Semiautomated Patient Prescreening in Cancer Clinical Trials.

JCO clinical cancer informatics·2026
Same author

Applications of machine learning and natural language processing to neurocognitive outcomes in posttreatment cancer survivors: a scoping review.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Clinical characteristics and outcomes for 7,995 patients with SARS-CoV-2 infection.

PloS one·2021

Related Experiment Video

Updated: May 16, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

A Natural Language Processing Framework for Structuring and Visualizing Clinical Trial Eligibility Criteria at Scale:

Justin Xie1, Jeet Parikh1, Jessica Liu2

  • 1Yale College, Yale University, New Haven, CT, United States.

JMIR Research Protocols
|May 14, 2026
PubMed
Summary

This study developed a scalable system using natural language processing and large language models (LLMs) to standardize clinical trial eligibility criteria, improving patient-trial matching and revealing trends. The system achieved 94% accuracy in categorizing criteria, aiding future trial design.

Keywords:
breast neoplasmsclinical trials as topiccluster analysisdata visualizationeligibility determinationgastrointestinal neoplasmslarge language modelslung neoplasmsmachine learningnatural language processing

Related Experiment Videos

Last Updated: May 16, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

Area of Science:

  • Computational biology
  • Bioinformatics
  • Clinical informatics

Background:

  • Clinical trial eligibility criteria are crucial but often complex, hindering patient recruitment and data analysis.
  • Manual review of criteria is inefficient and prone to errors.
  • Natural language processing (NLP) and large language models (LLMs) offer potential solutions for standardizing and analyzing eligibility criteria at scale.

Purpose of the Study:

  • To develop and evaluate a scalable system using LLM-enabled NLP and unsupervised learning to identify, normalize, categorize, and visualize clinical trial eligibility criteria.
  • To enhance patient-trial matching and identify domain-level trends in trial eligibility.

Main Methods:

  • A three-part pipeline was designed: text representation with embeddings and clustering, dual-layer LLM summarization for normalization and deduplication, and an interactive visualization interface.
  • The pipeline was applied to 53,872 oncology trials from ClinicalTrials.gov.
  • Feasibility was assessed through end-to-end processing and validation of cluster coherence and domain-specific patterns.

Main Results:

  • The system successfully processed all trials, generating stable clusters of inclusion/exclusion criteria.
  • LLM summarization produced concise, non-redundant labels, improving interpretability.
  • The visualization interface facilitated exploration of cross-trial patterns and temporal trends, identifying enrollment barriers.
  • Human validation confirmed 94% accuracy in categorizing criteria.

Conclusions:

  • A combined embeddings-clustering-LLM pipeline effectively standardizes heterogeneous eligibility text and reveals domain-level patterns.
  • This framework accelerates patient-trial matching and informs future clinical trial design.
  • The approach is generalizable to other diseases and adaptable to different modeling configurations.